Skip to main content
OpenTrials

Clinical trial condition

Esophageal Diseases

Explore clinical trials studying Esophageal Diseases. Study availability and eligibility vary by location and protocol.

3,578 public trials 730 recruiting studies
Refine in advanced search Browse all conditions

Esophageal Diseases trial results

Completed

A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

NCT00002304

Conditions
AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +27 more
Locations
  • Good Samaritan Med Ctr Phoenix, Arizona, United States
  • Arkansas Children's Hosp Little Rock, Arkansas, United States
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • Eisenhower Med Ctr Rancho Mirage, California, United States
View all 42 locations
View Trial Details
Terminated

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

NCT04949256

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
Locations
  • City of Hope ( Site 0102) Duarte, California, United States
  • MedStar Washington Hospital Center ( Site 0186) Washington D.C., District of Columbia, United States
  • James Graham Brown Cancer Center ( Site 0117) Louisville, Kentucky, United States
  • Norton Cancer Institute ( Site 0116) Louisville, Kentucky, United States
View all 198 locations
View Trial Details
Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Terminated

A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)

NCT03281369

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, +7 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Uni of Southern California Los Angeles, California, United States
  • UCLA Jonsson Comprehensive Cancer Center Santa Monica, California, United States
  • Columbia University Medical Center New York, United States
View all 28 locations
View Trial Details

Related conditions